Document Detail

Effects of althesin in psychotherapy of schizophrenics. Preliminary report.
MedLine Citation:
PMID:  7282415     Owner:  NLM     Status:  MEDLINE    
Althesin infusions in subhypnotic dosage were given as a possible supportive agent during psychotherapy sessions in 6 chronic schizophrenics nonresponsive to neuroleptics and hardly amenable to psychotherapy. Speech content analysis (Gottschalk-Gleser method) of the therapy sessions of 2 patients gave the impression that there was lower hostility during Althesin sessions whereas anxiety was less influenced. The scoring from 2 patients in a self-rating scale on the state of wellbeing supported in impression of a beneficial effect of Althesin. Negative feelings were decreased and patients appeared to be more assertive.
W Ladisich
Related Documents :
10808475 - Finding the neutral position: patient and analyst perspectives.
191935 - Anorexia nervosa: a combined therapeutic approach.
23159585 - Novel evaluation of nephrolithiasis complicated in gout: a cross-sectional study using ...
3786605 - Measurement of obsessive-compulsive symptomatology: utility of the hopkins symptom chec...
287775 - Bone loss of edentulous alveolar ridges.
20923575 - Levels of (1→3)-β-d-glucan, candida mannan and candida dna in serum samples of pediatri...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Acta psychiatrica Belgica     Volume:  80     ISSN:  0300-8967     ISO Abbreviation:  Acta Psychiatr Belg     Publication Date:    1980 Jul-Aug
Date Detail:
Created Date:  1981-11-18     Completed Date:  1981-11-18     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  0247037     Medline TA:  Acta Psychiatr Belg     Country:  BELGIUM    
Other Details:
Languages:  eng     Pagination:  445-51     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Alfaxalone Alfadolone Mixture / therapeutic use*
Hostility / drug effects
Psychiatric Status Rating Scales
Schizophrenia / drug therapy,  therapy*
Verbal Behavior / drug effects
Reg. No./Substance:
8067-82-1/Alfaxalone Alfadolone Mixture

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Therapeutic trials in schizophrenia with dialysis. State of the art and one case study (author's tra...
Next Document:  Low prolactin levels in cerebrospinal fluid: an after effect of lobotomy in chronic schizophrenia.